October 10, 2022

Mental Health R&D: A Global Priority

Date and time

October 10, 2022 ~ October 10, 2022

In commemorating World Mental Health Day on October 10th, we are proud to have hosted the virtual event, “Mental Health R&D: A Global Priority,” gathering some of the world’s leading researchers, drug developers, and clinicians to critically examine the state of treatment, and better align our R&D efforts to the WHO’s initiative in Making Mental Health & Well-Being for All a Global Priority.

This is the 11th episode of our WuXi AppTec’s “Collaborations That Transform” series highlighting the importance of working collaboratively to solve industry-wide problems so that we can bring transformational medicines faster to patients. In this spirit, we’ve hosted a series of events this year, including WuXi Global Forum 2022, WuXi Healthcare Forum 2022, Rising to the Challenge: Healthy Aging Forum 2022, Fragile X Syndrome: Innovative Approaches to Finding a Cure, and Moving the Needle on ALS & Neuromuscular Disorders.

To view the on-demand videos of each session, please visit our YouTube channel.

Special thanks to our distinguished global leaders who spoke at this event, and our supportive partners.

Please follow us on Twitter and LinkedIn, and visit our WXPress website to stay up-to-date on upcoming WuXi AppTec news and events.

Agenda

08:00 AM - 08:05 AM Welcome
Hui Cai, Program Chair, VP and Head of Content, WuXi AppTec
08:05 AM - 08:35 AM Urgent Attention to Address Mental Health
Cara Altimus, Senior Director, Center for Strategic Philanthropy, Milken Institute
Daniel Fung, CEO, Institute of Mental Health in Singapore
John Krystal, Chair, Department of Psychiatry; Robert L. McNeil, Jr. Professor of Translational Research, Yale University
08:35 AM - 09:25 AM Latest Therapeutic Developments in Mental Health
John Dunlop, Head of Research & Development, Neumora
Murali Gopalakrishnan, Global Head, Neuroscience Search & Evaluation, Corporate Strategy Office, AbbVie
Barry Greene, CEO and Member of Board of Directors, Sage Therapeutics
Ekaterina Malievskaia, Co-Founder & Chief Innovation Officer, COMPASS Pathways
Brigitte (Bigs) Robertson, CMO, Delix Therapeutics
Moderator: Lauren Martz, Executive Director, Biopharma Intelligence, BioCentury
09:25 AM - 09:45 AM Challenges and Opportunities towards the Future of Mental Health Care
Ben Robbins, General Partner, GV
Daphne Zohar, Founder & CEO, PureTech Health
09:45 AM - 09:50 AM Closing Remarks
Richard Soll, Head of Boston Office and Senior Advisor of Strategic Initiatives, WuXi AppTec

Speakers

Hui Cai
PROGRAM CHAIR, VP AND HEAD OF CONTENT, WUXI APPTEC
Cara Altimus
SENIOR DIRECTOR, CENTER FOR STRATEGIC PHILANTHROPY, MILKEN INSTITUTE
Daniel Fung
CEO, INSTITUTE OF MENTAL HEALTH IN SINGAPORE
John Krystal
CHAIR, DEPARTMENT OF PSYCHIATRY; ROBERT L. MCNEIL, JR. PROFESSOR OF TRANSLATIONAL RESEARCH, YALE UNIVERSITY
John Dunlop
HEAD OF RESEARCH & DEVELOPMENT, NEUMORA
Murali Gopalakrishnan
GLOBAL HEAD, NEUROSCIENCE SEARCH & EVALUATION, CORPORATE STRATEGY OFFICE, ABBVIE
Barry Greene
CEO AND MEMBER OF BOARD OF DIRECTORS, SAGE THERAPEUTICS
Ekaterina Malievskaia
CO-FOUNDER & CHIEF INNOVATION OFFICER, COMPASS PATHWAYS
Brigitte (Bigs) Robertson
CMO, DELIX THERAPEUTICS
Lauren Martz
EXECUTIVE DIRECTOR, BIOPHARMA INTELLIGENCE, BIOCENTURY
Ben Robbins
GENERAL PARTNER, GV
Daphne Zohar
FOUNDER & CEO, PURETECH HEALTH
Richard Soll
HEAD OF BOSTON OFFICE AND SENIOR ADVISOR OF STRATEGIC INITIATIVES, WUXI APPTEC